HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model

by Kamira Maharaj, Kamira Maharaj, John J. Powers, Melanie Mediavilla-Varela, Alex Achille, Wael Gamal, Wael Gamal, Steven Quayle, Simon S. Jones, Eva Sahakian, Eva Sahakian, Javier Pinilla-Ibarz, Javier Pinilla-Ibarz
Published 2020-11-01